Literature DB >> 20626558

Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice.

Mikko Käenmäki1, Anne Tammimäki, Timo Myöhänen, Kaisa Pakarinen, Carolina Amberg, Maria Karayiorgou, Joseph A Gogos, Pekka T Männistö.   

Abstract

Catechol-O-methyltransferase (COMT) plays an active role in the metabolism of dopamine (DA) in the prefrontal cortex (PFC). Because of low levels of dopamine transporter (DAT), it is proposed that the majority of released DA is taken up by either norepinephrine transporter (NET) and subsequently metabolized by monoamine oxidize (MAO) or by uptake(2) (to glial cells and post-synaptic neurons) and metabolized by COMT. However, a comprehensive in vivo study of rating the mechanisms involved in DA clearance in the PFC has not been done. Here, we employ two types of microdialysis to study these pathways using DAT, NET and MAO blockers in conscious mice, with or without Comt gene disruption. In quantitative no-net-flux microdialysis, DA levels were increased by 60% in the PFC of COMT-knockout (ko) mice, but not in the striatum and nucleus accumbens. In conventional microdialysis studies, we showed that selective NET and MAO inhibition increased DA levels in the PFC of wild-type mice by two- to fourfold, an effect that was still doubled in COMT-ko mice. Inhibition of DAT had no effect on DA levels in either genotype. Therefore, we conclude that in the mouse, PFC COMT contributes about one half of the total DA clearance.
© 2010 The Authors. Journal Compilation © 2010 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20626558     DOI: 10.1111/j.1471-4159.2010.06889.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  80 in total

1.  Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.

Authors:  Doron Gothelf; Amanda J Law; Amos Frisch; Jingshan Chen; Omer Zarchi; Elena Michaelovsky; Renee Ren-Patterson; Barbara K Lipska; Miri Carmel; Bhaskar Kolachana; Abraham Weizman; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2013-08-28       Impact factor: 13.382

2.  Differential COMT expression and behavioral effects of COMT inhibition in male and female Wistar and alcohol preferring rats.

Authors:  Aqilah M McCane; Michael J DeLory; Maureen M Timm; Sarine S Janetsian-Fritz; Christopher C Lapish; Cristine L Czachowski
Journal:  Alcohol       Date:  2017-08-19       Impact factor: 2.405

Review 3.  Executive (dys)function after stroke: special considerations for behavioral pharmacology.

Authors:  Jessica M Povroznik; Jenny E Ozga; Cole Vonder Haar; Elizabeth B Engler-Chiurazzi
Journal:  Behav Pharmacol       Date:  2018-10       Impact factor: 2.293

4.  Association between the COMT Val158Met polymorphism and fibromyalgia susceptibility and fibromyalgia impact questionnaire score: a meta-analysis.

Authors:  Young Ho Lee; Jae-Hoon Kim; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2014-06-21       Impact factor: 2.631

5.  A frontal dopamine system for reflective exploratory behavior.

Authors:  Nathaniel J Blanco; Bradley C Love; Jessica A Cooper; John E McGeary; Valerie S Knopik; W Todd Maddox
Journal:  Neurobiol Learn Mem       Date:  2015-05-22       Impact factor: 2.877

6.  A preliminary study suggests that nicotine and prefrontal dopamine affect cortico-striatal areas in smokers with performance feedback.

Authors:  M R Lee; C L Gallen; T J Ross; P Kurup; B J Salmeron; C A Hodgkinson; D Goldman; E A Stein; M A Enoch
Journal:  Genes Brain Behav       Date:  2013-04-11       Impact factor: 3.449

7.  Anatomical and pharmacological characterization of catecholamine transients in the medial prefrontal cortex evoked by ventral tegmental area stimulation.

Authors:  Tatiana A Shnitko; Donita L Robinson
Journal:  Synapse       Date:  2013-11-28       Impact factor: 2.562

8.  Optimization of 8-Hydroxyquinolines as Inhibitors of Catechol O-Methyltransferase.

Authors:  Ingrid Buchler; Daniel Akuma; Vinh Au; Gregory Carr; Pablo de León; Michael DePasquale; Glen Ernst; Yifang Huang; Martha Kimos; Anna Kolobova; Michael Poslusney; Huijun Wei; Dominique Swinnen; Florian Montel; Florence Moureau; Emilie Jigorel; Monika-Sarah E D Schulze; Martyn Wood; James C Barrow
Journal:  J Med Chem       Date:  2018-10-19       Impact factor: 7.446

9.  Prolyl Oligopeptidase Regulates Dopamine Transporter Phosphorylation in the Nigrostriatal Pathway of Mouse.

Authors:  Ulrika H Julku; Anne E Panhelainen; Saija E Tiilikainen; Reinis Svarcbahs; Anne E Tammimäki; T Petteri Piepponen; Mari H Savolainen; Timo T Myöhänen
Journal:  Mol Neurobiol       Date:  2016-12-13       Impact factor: 5.590

10.  COMT Genetic Reduction Produces Sexually Divergent Effects on Cortical Anatomy and Working Memory in Mice and Humans.

Authors:  Sara Sannino; Alessandro Gozzi; Antonio Cerasa; Fabrizio Piras; Diego Scheggia; Francesca Managò; Mario Damiano; Alberto Galbusera; Lucy C Erickson; Davide De Pietri Tonelli; Angelo Bifone; Sotirios A Tsaftaris; Carlo Caltagirone; Daniel R Weinberger; Gianfranco Spalletta; Francesco Papaleo
Journal:  Cereb Cortex       Date:  2014-03-21       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.